Trump Calls Out Biden on Weaponizing Government: Fight for Yourself
Justice Barrett Explains the Message Americans Should Take Away From the Trump Ballot...
Liberal Media Melts Down After SCOTUS Rules States Can’t Remove Trump From 2024...
Polls Are Shifting
The Bidenomics Website the White House Doesn't Want You to See
SCOTUS Rules Unanimously on Trump Ballot Case
Maine's Secretary of State Makes Announcement Following SCOTUS's 14th Amendment Ruling
The Biden Administration's Use of This Word to Describe Illegal Immigrants Prompts Outrage
Fears of 'Environmental Disaster' Grow As Ship Attacked by Houthis Sinks
One MLB Team Will No Longer Be Permitted to Kneel During the National...
The Majority of Scientists Agree That Sex Is Binary, New Poll Shows
Germany: the Socialism/Capitalism Experiment
An Accused Bandit Who Robbed Illegal Immigrants Was Shot and Killed by Border...
Did You Notice What Was Missing From Biden's Border Photo-Op?
One New York County Took a Step to Protect Women's Sports. Here's How...

Despite Delta Fears, Stay-At-Home Stocks Struggle

The opinions expressed by columnists are their own and do not necessarily represent the views of
AP Photo/Eugene Hoshiko

Wednesday was another solid session for cyclical names, particularly Materials (XLB) on movement with infrastructure. However, after a strong bond auction, the session got an extra boost, which says foreigner demand pushed yields lower.


To see the chart, click here.

Sector Watch

Keep an eye on Materials - to rally to form a double top -a breakout there would be monumental and spark a much higher move.

Industrials ,also sporting an intriguing chart, has come on strong. The sector has significantly underperformed the S&P over the past six months.

Internals Still Lousy

Market breadth was strong on the New York Stock Exchange (NYSE), reflecting a shift to value, quality, and cyclical names, while the NASDAQ Composite struggled in all measures.

Market Breadth









52 Week High



52 Week Low



Up Volume



Down Volume



FDA Booster Shot

The U.S. Food and Drug Administration (FDA) is ready to authorize a Covid-19 booster shot. Perhaps that’s why so-called stay-at-home or work-from-home names took it on the chin. And reopening stocks found buyers even with elevated Delta variant cases and increased hospitalizations.


Portfolio Approach

We took profits in Healthcare this morning in our Hotline Model Portfolio.

Inflation Picture / Core PPI

For the fifth month in a row, PPI core has come in much hotter than Wall Street consensus – this time twice the consensus of +0.5% - matching the second highest number ever. 

Producer prices continued marching higher – climbing 7.8% from 7.3% - hitting the higher level ever (data kept since Nov 2010).

Lots of noise in the PPI report we need to comb through…but the bias remains to the upside.

Join the conversation as a VIP Member


Trending on Townhall Videos